Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LAZARO A SALGADO

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1700411188
CMS profile
8343905
Location
MIAMI, FL

General Payments · PY2022–2024

$504.28

  • Reported across 24 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$310.88

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $310.88 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Medtronic, Inc. $71.39 1
Otsuka America Pharmaceutical, Inc. $37.85 2
Novo Nordisk AS $34.72 2
Amgen Inc. $32.18 2
PFIZER INC. $32.13 2
Janssen Pharmaceuticals, Inc $30.53 2
Abbott Laboratories $21.77 1
Acerta Pharma LLC $17.63 1
Lilly USA, LLC $16.73 1
Exact Sciences Corporation $15.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $49.14 2
PY2023 $144.26 7
PY2024 $310.88 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $21.77 03/07/2024 Food and Beverage Undisputed 01/23/2026 1125208357 CMS
Amgen Inc. $13.27 09/27/2024 Food and Beverage Undisputed 01/23/2026 1117372636 CMS
Amgen Inc. $18.91 10/08/2024 Food and Beverage Undisputed 01/23/2026 1117372638 CMS
AstraZeneca Pharmaceuticals LP $17.63 05/15/2024 Food and Beverage Undisputed 01/23/2026 1105697686 CMS
Exact Sciences Corporation $15.95 03/05/2024 Food and Beverage Undisputed 01/23/2026 1114418045 CMS
Janssen Pharmaceuticals, Inc $14.93 04/10/2024 Food and Beverage Undisputed 01/23/2026 1077961392 CMS
Janssen Pharmaceuticals, Inc $15.60 06/19/2024 Food and Beverage Undisputed 01/23/2026 1077961226 CMS
Lilly USA, LLC $16.73 06/12/2024 Food and Beverage Undisputed 01/23/2026 1135763961 CMS
Medtronic, Inc. $71.39 02/12/2024 Food and Beverage Undisputed 01/23/2026 1116981363 CMS
Novo Nordisk Inc $16.39 04/01/2024 Food and Beverage Undisputed 01/23/2026 1100325186 CMS
Novo Nordisk Inc $18.33 11/06/2024 Food and Beverage Undisputed 01/23/2026 1100479321 CMS
Otsuka America Pharmaceutical, Inc. $22.52 05/16/2024 Food and Beverage Undisputed 01/23/2026 1119177964 CMS
Otsuka America Pharmaceutical, Inc. $15.33 06/07/2024 Food and Beverage Undisputed 01/23/2026 1119177966 CMS
PFIZER INC. $17.38 03/19/2024 Food and Beverage Undisputed 01/23/2026 1132033115 CMS
PFIZER INC. $14.75 10/16/2024 Food and Beverage Undisputed 01/23/2026 1130886110 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.